Inicio Zine News AVRA Medical Robotics Initiates Food and Drug Administration Approval Process

AVRA Medical Robotics Initiates Food and Drug Administration Approval Process

2
0

ORLANDO, Fla., Aug. 28, 2019 (GLOBE NEWSWIRE) -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), an emerging growth company that is in the process of building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence, machine learning and proprietary software; announced today that its regulatory and management teams met with the Food and Drug Administration (FDA) on August 12th. The Company’s robot arm has already won approval in the EU and received the CE mark. The Company has begun implementing a quality and regulatory system that will serve as the foundation for US, Canadian, European, Australian, Japanese, and Brazilian market access for AVRA’s modern medical robotic system – a ground-breaking approach to medical robotics. The Medical Device Single Audit Program (MDSAP), which the Company is employing, is a single inspection that, when completed, is expected to support market access to the six most important medical device marketplaces.